Group 2 innate lymphoid cells promote inhibitory synapse development and social behavior.


Journal

Science (New York, N.Y.)
ISSN: 1095-9203
Titre abrégé: Science
Pays: United States
ID NLM: 0404511

Informations de publication

Date de publication:
Nov 2024
Historique:
medline: 1 11 2024
pubmed: 1 11 2024
entrez: 31 10 2024
Statut: ppublish

Résumé

The innate immune system shapes brain development and is implicated in neurodevelopmental diseases. It is critical to define the relevant immune cells and signals and their impact on brain circuits. In this work, we found that group 2 innate lymphoid cells (ILC2s) and their cytokine interleukin-13 (IL-13) signaled directly to inhibitory interneurons to increase inhibitory synapse density in the developing mouse brain. ILC2s expanded and produced IL-13 in the developing brain meninges. Loss of ILC2s or IL-13 signaling to interneurons decreased inhibitory, but not excitatory, cortical synapses. Conversely, ILC2s and IL-13 were sufficient to increase inhibitory synapses. Loss of this signaling pathway led to selective impairments in social interaction. These data define a type 2 neuroimmune circuit in early life that shapes inhibitory synapse development and behavior.

Identifiants

pubmed: 39480923
doi: 10.1126/science.adi1025
doi:

Substances chimiques

Interleukin-13 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

eadi1025

Commentaires et corrections

Type : CommentIn

Auteurs

Jerika J Barron (JJ)

Department of Psychiatry and Behavioral Sciences-Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA 94158, USA.
Biomedical Sciences Graduate Program, University of California, San Francisco, San Francisco, CA 94158, USA.

Nicholas M Mroz (NM)

Biomedical Sciences Graduate Program, University of California, San Francisco, San Francisco, CA 94158, USA.
Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA 94158, USA.

Sunrae E Taloma (SE)

Neuroscience Graduate Program, University of California, San Francisco, San Francisco, CA 94158, USA.
Kavli Institute for Fundamental Neurosciences, University of California, San Francisco, San Francisco, CA 94158, USA.
Department of Neurology, University of California, San Francisco, San Francisco, CA 94158, USA.

Madelene W Dahlgren (MW)

Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA 94158, USA.
Lung Biology, Department of Experimental Medical Science, Lund University, Lund, Sweden.

Jorge F Ortiz-Carpena (JF)

Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA 94158, USA.

Matthew G Keefe (MG)

Department of Psychiatry and Behavioral Sciences-Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA 94158, USA.
Developmental and Stem Cell Biology Graduate Program, University of California, San Francisco, San Francisco, CA 94158, USA.

Caroline C Escoubas (CC)

Department of Psychiatry and Behavioral Sciences-Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA 94158, USA.

Leah C Dorman (LC)

Department of Psychiatry and Behavioral Sciences-Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA 94158, USA.
Chan-Zuckerberg Biohub, San Francisco, CA 94158, USA.

Ilia D Vainchtein (ID)

Department of Psychiatry and Behavioral Sciences-Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA 94158, USA.

Pailin Chiaranunt (P)

Department of Psychiatry and Behavioral Sciences-Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA 94158, USA.
Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA 94158, USA.

Maya E Kotas (ME)

Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA 94158, USA.

Tomasz J Nowakowski (TJ)

Department of Psychiatry and Behavioral Sciences-Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA 94158, USA.
Department of Anatomy, University of California, San Francisco, San Francisco, CA 94158, USA.

Kevin J Bender (KJ)

Kavli Institute for Fundamental Neurosciences, University of California, San Francisco, San Francisco, CA 94158, USA.
Department of Neurology, University of California, San Francisco, San Francisco, CA 94158, USA.

Ari B Molofsky (AB)

Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA 94158, USA.

Anna V Molofsky (AV)

Department of Psychiatry and Behavioral Sciences-Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA 94158, USA.
Kavli Institute for Fundamental Neurosciences, University of California, San Francisco, San Francisco, CA 94158, USA.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH